87 related articles for article (PubMed ID: 17244920)
1. Clinical significance of p53 gene mutation in T1-2N0 non-small cell lung cancer.
Gebitekin C; Bayram AS; Tunca B; Balaban SA
Asian Cardiovasc Thorac Ann; 2007 Jan; 15(1):35-8. PubMed ID: 17244920
[TBL] [Abstract][Full Text] [Related]
2. Exon 8 mutation of p53 gene associated with nodal metastasis in non-small-cell lung cancer.
Lee LN; Shew JY; Sheu JC; Lee YC; Lee WC; Fang MT; Chang HF; Yu CJ; Yang PC; Luh KT
Am J Respir Crit Care Med; 1994 Dec; 150(6 Pt 1):1667-71. PubMed ID: 7952630
[TBL] [Abstract][Full Text] [Related]
3. [Evaluation of the prognostic significance of P53 mutation in patients with non-small cell lung cancer].
Jassem E; Rosell R; Jassem J; Monzo M; Kobierska G; Badzio A; Roszkiewicz A; Skokowski J; Szulc A
Pneumonol Alergol Pol; 1998; 66(5-6):290-6. PubMed ID: 9857649
[TBL] [Abstract][Full Text] [Related]
4. Is mediastinoscopy still the gold standard to evaluate mediastinal lymph nodes in patients with non-small cell lung carcinoma?
Sivrikoz CM; Ak I; Simsek FS; Döner E; Dündar E
Thorac Cardiovasc Surg; 2012 Mar; 60(2):116-21. PubMed ID: 21692019
[TBL] [Abstract][Full Text] [Related]
5. The yield of mediastinoscopy with respect to lymph node size, cell type, and the location of the primary tumor.
Fibla JJ; Molins L; Simon C; Perez J; Vidal G
J Thorac Oncol; 2006 Jun; 1(5):430-3. PubMed ID: 17409895
[TBL] [Abstract][Full Text] [Related]
6. [Risk factor analysis of mediastinal lymph node metastasis in non-small cell lung cancer patients and the strategy of mediastinoscopy prior to surgery].
Wang X; Zheng L; Zhang SY; Xie ZM; Yu H; Su XD; Wang JY; Huang ZF; Yang MT; Rong TH
Zhonghua Zhong Liu Za Zhi; 2009 Jun; 31(6):456-9. PubMed ID: 19950559
[TBL] [Abstract][Full Text] [Related]
7. Genetic evolutionary staging of early non-small cell lung cancer: the P53 --> HER-2/NEU --> ras sequence.
Shackney SE; Smith CA; Pollice A; Levitt M; Magovern JA; Wiechmann RJ; Silverman J; Sweeney L; Landreneau RJ
J Thorac Cardiovasc Surg; 1999 Aug; 118(2):259-67. PubMed ID: 10424999
[TBL] [Abstract][Full Text] [Related]
8. The role of extended cervical mediastinoscopy in staging of non-small cell lung cancer of the left lung and a comparison with integrated positron emission tomography and computed tomography: does integrated positron emission tomography and computed tomography reduce the need for invasive procedures?
Metin M; Citak N; Sayar A; Pekcolaklar A; Melek H; Kök A; Gurses A
J Thorac Oncol; 2011 Oct; 6(10):1713-9. PubMed ID: 21716145
[TBL] [Abstract][Full Text] [Related]
9. Repeat mediastinoscopy in all its indications: experience with 96 patients and 101 procedures.
Call S; Rami-Porta R; Obiols C; Serra-Mitjans M; Gonzalez-Pont G; Bastús-Piulats R; Quintana S; Belda-Sanchis J
Eur J Cardiothorac Surg; 2011 Jun; 39(6):1022-7. PubMed ID: 21112217
[TBL] [Abstract][Full Text] [Related]
10. Mediastinoscopy might not be necessary in patients with non-small cell lung cancer with mediastinal lymph nodes having a maximum standardized uptake value of less than 5.3.
Lee BE; Redwine J; Foster C; Abella E; Lown T; Lau D; Follette D
J Thorac Cardiovasc Surg; 2008 Mar; 135(3):615-9. PubMed ID: 18329480
[TBL] [Abstract][Full Text] [Related]
11. p53 alterations in non-small cell lung cancers correlate with metastatic involvement of hilar and mediastinal lymph nodes.
Marchetti A; Buttitta F; Merlo G; Diella F; Pellegrini S; Pepe S; Macchiarini P; Chella A; Angeletti CA; Callahan R
Cancer Res; 1993 Jun; 53(12):2846-51. PubMed ID: 8389245
[TBL] [Abstract][Full Text] [Related]
12. Comparison of oncogene mutation detection and telomerase activity for the molecular staging of non-small cell lung cancer.
Ahrendt SA; Yang SC; Wu L; Westra WH; Jen J; Califano JA; Sidransky D
Clin Cancer Res; 1997 Jul; 3(7):1207-14. PubMed ID: 9815801
[TBL] [Abstract][Full Text] [Related]
13. [The role of positron emission tomography (PET) in mediastinal staging of non-small cell lung cancer].
Melek H; Günlüoğlu MZ; Demir A; Akin H; Medetoğlu B; Kara HV; Olçmen A; Dinçer SI
Tuberk Toraks; 2008; 56(1):56-63. PubMed ID: 18330756
[TBL] [Abstract][Full Text] [Related]
14. Outcomes of mediastinoscopy and surgery with or without neoadjuvant therapy in patients with non-small cell lung cancer who are N2 negative on positron emission tomography and computed tomography.
Kim HK; Choi YS; Kim K; Shim YM; Park K; Ahn YC; Lee KS; Choi JY; Kim J
J Thorac Oncol; 2011 Feb; 6(2):336-42. PubMed ID: 21164366
[TBL] [Abstract][Full Text] [Related]
15. Plasma DNA, microsatellite alterations, and p53 tumor mutations are associated with disease-free survival in radically resected non-small cell lung cancer patients: a study of the perugia multidisciplinary team for thoracic oncology.
Ludovini V; Pistola L; Gregorc V; Floriani I; Rulli E; Piattoni S; Di Carlo L; Semeraro A; Darwish S; Tofanetti FR; Stocchi L; Mihaylova Z; Bellezza G; Del Sordo R; Daddi G; Crinò L; Tonato M
J Thorac Oncol; 2008 Apr; 3(4):365-73. PubMed ID: 18379354
[TBL] [Abstract][Full Text] [Related]
16. [Clinical value of cervical mediastinoscopy in non-small cell lung cancer of stage I].
Zhang SY; Wang X; Zhu ZH; Zeng CG; Rong TH; Zheng L; Fu JH; Xie ZM; Zhang X; Yu H
Ai Zheng; 2005 Mar; 24(3):349-52. PubMed ID: 15757540
[TBL] [Abstract][Full Text] [Related]
17. Prospective comparative study of integrated positron emission tomography-computed tomography scan compared with remediastinoscopy in the assessment of residual mediastinal lymph node disease after induction chemotherapy for mediastinoscopy-proven stage IIIA-N2 Non-small-cell lung cancer: a Leuven Lung Cancer Group Study.
De Leyn P; Stroobants S; De Wever W; Lerut T; Coosemans W; Decker G; Nafteux P; Van Raemdonck D; Mortelmans L; Nackaerts K; Vansteenkiste J
J Clin Oncol; 2006 Jul; 24(21):3333-9. PubMed ID: 16849747
[TBL] [Abstract][Full Text] [Related]
18. Routine mediastinoscopy and esophageal ultrasound fine-needle aspiration in patients with non-small cell lung cancer who are clinically N2 negative: a prospective study.
Cerfolio RJ; Bryant AS; Eloubeidi MA
Chest; 2006 Dec; 130(6):1791-5. PubMed ID: 17166998
[TBL] [Abstract][Full Text] [Related]
19. High frequency of deletion mutations in p53 gene from squamous cell lung cancer patients in Taiwan.
Wang YC; Chen CY; Chen SK; Cherng SH; Ho WL; Lee H
Cancer Res; 1998 Jan; 58(2):328-33. PubMed ID: 9443413
[TBL] [Abstract][Full Text] [Related]
20. Poor correspondence between clinical and pathologic staging in stage 1 non-small cell lung cancer: results from CALGB 9761, a prospective trial.
D'Cunha J; Herndon JE; Herzan DL; Patterson GA; Kohman LJ; Harpole DH; Kernstine KH; Kern JA; Green MR; Maddaus MA; Kratzke RA;
Lung Cancer; 2005 May; 48(2):241-6. PubMed ID: 15829324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
